Comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases

Dermatologic Surgery

Volumn 25, Issue 6, 1999, Pages 463-467

  Goldberg, David J ^a,b   Meine, Jon G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Westwood Dermatology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; FACE DISORDER; FEMALE; HUMAN; LASER SURGERY; MALE; NEODYMIUM LASER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELAXATION TIME; TELANGIECTASIA; VASCULAR DISEASE; YAG LASER;

ADULT; AGED; FACIAL DERMATOSES; FEMALE; HUMANS; LASERS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; TELANGIECTASIS;

EID: 0033040095     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.1999.09021.x     Document Type: Article

References (30)

1. Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Dermatol 1987;17:167-82.
2. Goldman MP, Weiss RA, Brody HJ. Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodessication: a review. J Dermatol Surg Oncol 1993;19:899-906.
3. Ayres S Jr, Burrows LA, Anderson NP. Generalized telangiectasias and sinus infection: report of a case with cure by treatment of chronic sinusitis. Arch Dermatol Syph 1931;26:56-9.
4. Redisch W, Pelzer RH. Localized vascular dilations of the human skin: capillary microscopy and related studies. Am Heart J 1949; 37:106-14.
5. Apfelberg D, Maser M, Lash H. The argon laser for cutaneous lesions. JAMA 1981;245:2073-5.
6. Arndt KA. Argon laser therapy of small cutaneous vascular lesions. Arch Dermatol 1982;118:220-24.
7. McBurney EI. Clinical usefulness of the argon laser for the 1990's. J Dermatol Surg Oncol 1993;19:358-62.
8. 2 and flashlamp-pumped pulsed dye lasers. Adv Otorhinolaryngol 1995;49:81-6.
9. Landthaler M, Haina D, Brunner R, Waidelich W, Braun-Falco O. Neodymium-YAG laser therapy for vascular lesions. J Am Acad Dermatol 1986;14:107-17.
10. Dixon JA, Huether S, Rotering R. Hypertrophic scarring in argon laser treatment of port-wine stains. Plast Reconstr Surg 1984;73: 771-80.
11. Neumann RA, Knobler RM, Leonhartsberger H, Gebbhart W. Comparative histochemistry of port-wine stains after copper vapor laser (578) and argon laser treatment. J Invest Dermatol 1992;99: 160-67.
12. Tan OT, Carney JM, Margolis R, et al. Histologic responses of port-wine stains treated by argon, carbon dioxide, and tunable dye lasers. Arch Dermatol 1986;122:1016-22.
13. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-7.
14. Anderson RR, Parrish JA. Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981;1:263-76.
15. Gonzalez E, Gange RW, Momtaz KT. Treatment of telangiectases and other benign vascular lesions with the 577 nm pulsed dye laser. J Am Acad Dermatol 1992;27:220-26.
16. Ruiz-Esparza J, Goldman MP, Fitzpatrick RF, et al. Flashlamp pumped dye laser treatment of telangiectasia. J Dermatol Surg Oncol 1993;19:1000-1003.
17. Broska P, Martinho E, Goodman MM. Comparison of the argon tunable dye laser with the flashlamp pulsed dye laser in treatment of facial telangiectasia. J Dermatol Surg Oncol 1994;20:749-53.
18. Apfelberg DB. Argon-pumped tunable dye laser. Ann Plast Surg 1994;32:394-400.
19. Key JM, Waner M. Selective destruction of facial telangiectasia using a copper vapor laser. Arch Otolaryngol Head Neck Surg 1992; 118:509-13.
20. Dinehart SM, Waner M, Flock S. The copper vapor laser for treatment of cutaneous vascular and pigmented lesions. J Dermatol Surg Oncol 1993;19:370-75.
21. McCoy S, Hanna M, Anderson P, McLennan G, Repacholi M. An evaluation of the copper-bromide laser for treating telangiectasia. Dermatol Surg 1996;22:551-7.
22. Thibault PK. A patient's questionnaire evaluation of krypton laser treatment of facial telangiectases. Dermatol Surg 1997;23:37-41.
23. Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 1989;93:28-32.
24. Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. Arch Dermatol 1994;130:1515-9.
25. Kilmer SL, Anderson RR. Clinical use of the Q-switched Nd:YAG (1064 nm and 532 nm) lasers for treatment of tattoos. J Dermatol Surg Oncol 1993;19:330-38.
26. Kilmer SL, Lee MS, Anderson RR. Treatment of multi-colored tattoos with the Q-switched Nd:YAG laser (532): a dose-response study with comparison to the Q-switched ruby laser. Lasers Surg Med 1993;5(suppl):54.
27. Goldberg DJ, Marcus J. The use of the frequency-doubled Q-switched Nd:YAG laser in the treatment of small cutaneous vascular lesions. Dermatol Surg 1996;22:841-4.
28. Goldberg DJ, Meine JG. Treatment of facial telangiectases with the diode pumped frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg 1998;24:916-8.
29. Tan OT, Kerschmann R, Parrish JA. The effect of epidermal pigmentation on selective vascular effects of pulsed laser. Lasers Surg Med 1984;4:365-74.
30. Tong A, Tan O, Boll J, Parrish J, Murphy G. Ultrastructure: effects of melanin pigment of target specificity using a pulsed dye laser (577 nm). J Invest Dermatol 1987;88:747-52.